SNDX Stock Analysis: Buy, Sell, or Hold?
SNDX - Syndax Pharmaceuticals, Inc.
$21.35
1.04 (5.12%)
▲
5d:
-0.23%
30d:
+1.62%
90d:
+59.45%
HOLD
MODERATE Confidence
Last Updated: February 2, 2026
Earnings: Mar 02, 2026
26d
Get Alerted When SNDX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: SNDX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: SNDX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: SNDX is currently trading at $21.35, which is considered extended relative to its 30-day fair value range of $20.38 to $21.36.
Technical Outlook: Technically, SNDX is in a strong uptrend. Immediate support is located at $19.71, while resistance sits at $22.18. The stock is showing strong short-term momentum, up 5.1% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $39.31 (+84.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, SNDX is in a strong uptrend. Immediate support is located at $19.71, while resistance sits at $22.18. The stock is showing strong short-term momentum, up 5.1% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $39.31 (+84.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$20.38 -
$21.36
Company Quality Score
59/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
56.3%
All Signals
- BEARISH: Price extended above range
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+5.1%)
- BULLISH: Trading 84.1% below Wall St target ($39.31)
Fair Price Analysis
30-Day Fair Range
$20.38 -
$21.36
Current vs Fair Value
EXTENDED
Support & Resistance Levels
Support Level
$19.71
Resistance Level
$22.18
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-13.34
Wall Street Target
$39.31
(+84.1%)
Revenue Growth (YoY)
267.0%
Profit Margin
-279.9%
Last updated: February 03, 2026 2:38 AM ET
Data refreshes hourly during market hours. Next update: 3:38 AM
Data refreshes hourly during market hours. Next update: 3:38 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SNDX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
3
Sells
Net
INSIDERS SELLING
Recent Transactions
Michael A Metzger
SELL
157307 shares
2025-09-08
Dennis Podlesak
SELL
19200 shares
2025-08-18
Dennis Podlesak
SELL
19200 shares
2025-08-15
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$24 | 57 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1036 | 57 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$85 | 59 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$33 | 64 BUY |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
